CLINICAL TRIALS PROFILE FOR NEPAFENAC
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
All Clinical Trials for Nepafenac
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00330798 ↗ | A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief | Completed | Matthew Caldwell | Phase 4 | 2006-02-01 | The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery. |
| NCT00330798 ↗ | A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief | Completed | Alcon Research | Phase 4 | 2006-02-01 | The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery. |
| NCT00333255 ↗ | Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery | Completed | Alcon Research | Phase 3 | 2005-09-01 | The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic Suspension, 0.1% eye drops to Acular LS eye drops, used before and after cataract surgery, for treating inflammation in the eye. |
| NCT00377546 ↗ | Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1% | Completed | Innovative Medical | Phase 4 | 1969-12-31 | To compare the penetration of three different NSAIDs. |
| NCT00405730 ↗ | Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo | Completed | Alcon Research | Phase 3 | 2005-11-01 | To evaluate the safety and efficacy of Nepafenac 1 mg/ml Eye Drops, Suspension, compared to Placebo and Ketorolac Trometamol 5 mg/ml Eye Drops, Solution for the prevention and treatment of ocular inflammation and ocular pain after cataract extraction with IOL implantation |
| NCT00407017 ↗ | Therapeutic Variables in Cataract Surgery | Completed | Innovative Medical | Phase 4 | 1969-12-31 | The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits. |
| NCT00494494 ↗ | Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery | Completed | Research to Prevent Blindness | Phase 4 | 2007-06-01 | Purpose: Study the effect of nepafenac ophthalmic suspension 0.1% to prevent post-operative cystoid macular edema following uncomplicated cataract surgery Participants: Patients having cataract surgery at UNC who meet eligibility criteria Procedures (methods): Patients will have pre and post-operative vision measured and optical coherence tomography (OCT) testing, also cataract density and intraoperative phacoemulsification parameters including ultrasound power and ultrasound time will be measured. Patients will be randomized into two groups. Group 1 will be treated with standard post-operative cataract management. Group 2 will be treated with standard post-operative cataract management plus topical nepafenac for one month. Post-operative macular thickness will be studied by analyzing the visual acuity and OCT measurements at two months post surgery. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Nepafenac
Condition Name
Clinical Trial Locations for Nepafenac
Trials by Country
Clinical Trial Progress for Nepafenac
Clinical Trial Phase
Clinical Trial Sponsors for Nepafenac
Sponsor Name
